Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 7/20 | 1.00 |
| ▸ | MAOB | P27338 | 6/20 | 0.65 |
| ▸ | IDO1 | P14902 | 2/20 | 0.59 |
| ▸ | HTR2A | P28223 | 1/20 | 0.58 |
| ▸ | HTR2C | P28335 | 1/20 | 0.58 |
| ▸ | HTR2B | P41595 | 1/20 | 0.58 |
| ▸ | MIF | P14174 | 1/20 | 0.56 |
| ▸ | DRD2 | P14416 | 1/20 | 0.52 |
| ▸ | DRD1 | P21728 | 1/20 | 0.52 |
| ▸ | ACP3 | P15309 | 1/20 | 0.51 |
| ▸ | DAO | P14920 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL10899408 | 0.98 | TAAR1 (0.96) | TAAR1MAOBIDO1HTR2AHTR2C | |
| Iodide SCHEMBL31174197 | 0.98 | TAAR1 (0.96) | TAAR1MAOBIDO1HTR2AHTR2C | |
| Methane SCHEMBL28404139 | 0.98 | TAAR1 (0.96) | TAAR1MAOBIDO1HTR2AHTR2C | |
| Hydrochloric Acid SCHEMBL7318926 | 0.98 | TAAR1 (0.96) | TAAR1MAOBIDO1HTR2AHTR2C | |
| Iodide SCHEMBL28682768 | 0.98 | TAAR1 (0.96) | TAAR1MAOBIDO1HTR2AHTR2C | |
| Bromide SCHEMBL29203648 | 0.98 | TAAR1 (0.96) | TAAR1MAOBIDO1HTR2AHTR2C | |
| Hydrochloric Acid SCHEMBL10899419 | 0.96 | TAAR1 (0.93) | TAAR1MAOBIDO1HTR2AHTR2C | |
| Phenethylamine SCHEMBL10913595 | 0.94 | TAAR1 (0.89) | TAAR1MAOBIDO1HTR2AHTR2C | |
| SCHEMBL365289 | 0.89 | TAAR1 (0.79) | TAAR1MAOBIDO1HTR2AHTR2C | |
| Hydrochloric Acid SCHEMBL12520854 | 0.87 | TAAR1 (0.77) | TAAR1MAOBIDO1HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 646 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118922001-A | Carbon-based organic-inorganic perovskite solar cell based on 3-trifluoromethyl phenethylamine hydroiodidate modification | 河北工业大学 | 2024-11-08 | — | — | CN | claimed |
| CN-118843336-A | Method for preparing trans-perovskite solar cell through lead capturing agent interface modification | 中南大学 | 2024-10-25 | — | — | CN | claimed |
| CN-115057883-B | Two-dimensional perovskite white light material and preparation method and application thereof | 吉林大学 | 2024-05-17 | — | — | CN | claimed |
| CN-116813497-B | Amide compound and preparation method, pharmaceutical composition and application thereof | 天津匠新致成科技有限公司 | 2023-11-14 | — | — | CN | claimed |
| CN-117043140-A | Substituted pyrrolidin-2-ones, salts thereof and their use as herbicidal active substances | 拜耳公司 | 2023-11-10 | — | — | CN | claimed |
| WO-2023102750-A1 | FENFLURAMINE HAPTEN, AND PREPARATION METHOD THEREFOR AND USE THEREOF, FENFLURAMINE HAPTEN ARTIFICIAL ANTIGEN, AND FENFLURAMINE HAPTEN ANTIBODY | 华南农业大学 | 2023-06-15 | — | — | WO | claimed |
| CN-114276264-B | Fenfluramine hapten, artificial antigen, antibody, preparation method and application thereof | 华南农业大学 | 2022-12-16 | — | — | CN | claimed |
| CN-112094229-B | Synthesis method of 6- (trifluoromethyl) isoquinoline-5-alcohol | 苏州康润医药有限公司 | 2022-11-22 | — | — | CN | claimed |
| CN-115057883-A | Two-dimensional perovskite white light material and preparation method and application thereof | 吉林大学 | 2022-09-16 | — | — | CN | claimed |
| CN-114975897-A | Alkali metal cathode with stable circulation, preparation method thereof and alkali metal battery | 苏州纳谷新材料科技有限公司 | 2022-08-30 | — | — | CN | claimed |
| EP-1401841-B1 | SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN | GRUENENTHAL GMBH (DE) | 2005-08-24 | — | — | EP | claimed |
| WO-2004089416-A2 | COMBINATION OF AN 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITOR AND AN ANTIHYPERTENSIVE AGENT | NOVO NORDISK A/S (DK) | 2004-10-21 | — | — | WO | claimed |
| WO-2004089470-A2 | NEW AMIDE DERIVATIVES AND PHARMACEUTICAL USE THEREOF | NOVO NORDISK A/S (DK) | 2004-10-21 | — | — | WO | claimed |
| WO-2004089415-A2 | COMBINATIONS OF AN 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITOR AND A GLUCOCORTICOID RECEPTOR AGONIST | NOVO NORDISK A/S (DK) | 2004-10-21 | — | — | WO | claimed |
| US-20040171554-A1 | Compositions and methods for enhancing apoptosis | GENENTECH, INC. | 2004-09-02 | — | — | US | claimed |
| EP-1370562-A1 | THIENO[2,3-D]PYRIMIDINDIONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS | Warner-Lambert Company LLC (US) | 2003-12-17 | — | — | EP | claimed |
| WO-2002064598-A1 | THIENO'2,3-D PYRIMIDINDIONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS | WARNER-LAMBERT COMPANY LLC (US) | 2002-08-22 | — | — | WO | claimed |
| EP-0403360-A2 | Use of phenylethanolamines for the preparation of a medicament for treating ophthalmologic disorders | SANOFI (FR) | 1990-12-19 | — | — | EP | claimed |
| EP-0255415-A2 | Use of phenylethanolamines for the preparation of medicaments acting on gastrointestinal troubles | ELF SANOFI (FR) | 1988-02-03 | — | — | EP | claimed |
| EP-0052963-B1 | SECONDARY AMINES | BEECHAM GROUP PLC (GB) | 1985-02-20 | — | — | EP | claimed |